- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02739321
Examining the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD
A Randomized, Cross-Over Study of the Efficacy of Mattress Technology in Improving the Sleep Quality of Children With ASD and Sleep Disturbances
The purpose of the present study is to evaluate the tolerability and efficacy of the Sound To Sleep System™ in improving the sleep quality of children with Autism Spectrum Disorder (ASD). The Sound To Sleep System™ is a mattress foundation designed to improve sleep quality in individuals with ASD and sleep disturbance by providing mattress vibrations that accompany and sync with auditory stimulation. For the present study, the primary objectives are as follows:
* Study Aim 1 - To determine whether the use of the Sound To Sleep System™ in ASD-affected children with sleep disturbances is well tolerated as defined by group drop-out proportion due to issues with the mattress technology.
The study will also explore the following objectives:
- Study Aim 2 - To determine the efficacy of the Sound To Sleep System™ in improving sleep quality as measured by parent reported sleep quality in ASD-affected children with sleep disturbances. (Please note Study Aim 2 was changed from clinician-rated to parent-rated because we were not able to collect clinician-rated sleep quality information).
- Study Aim 3 - To determine the tolerability of the Sound To Sleep System™ as defined by study drop-out due to any reason and caregiver ratings of ease of mattress technology use.
- Study Aim 4 - To determine whether use of the mattress technology improves functioning as defined by secondary outcome measures.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The present study aims to evaluate the tolerability and efficacy of a new mattress technology in improving the sleep quality of children with Autism Spectrum Disorder (ASD). Clinical and population studies indicate that children with ASD exhibit elevated rates of sleep disturbance compared to their typically-developing peers and that 50% to 80% of children with ASD have sleep problems. Sleep disturbance can include bedtime resistance, sleep onset latency, nighttime awakenings, decreased total sleep time, early morning awakenings, and other measures of sleep quality. Sleep problems in children with ASD are associated with greater externalizing and internalizing behavior problems during the waking day, poorer adaptive functioning, and can cause significant parental stress. Previous studies have examined the effectiveness of behavioral treatments, environmental modifications, melatonin, and psychopharmacologic treatments in decreasing the rates of sleep disturbance. However, none of these approaches have identified treatments that are effective for all ASD-affected children with sleep difficulties. Given the high prevalence of sleep disturbance in this population, there is a great need to identify additional treatments that may improve sleep in children with ASD.
The purpose of the present study is to evaluate the tolerability and efficacy of the Sound To Sleep System™ using a single blind (actigraphy scoring blinded), cross-over design. The Sound To Sleep System™ is a mattress foundation designed to improve sleep quality in individuals with ASD and sleep disturbance by providing mattress vibrations that accompany and sync with auditory stimulation. For the present study, the primary objectives are as follows:
Study Aim 1- To determine whether the use of the Sound To Sleep System™ in ASD-affected children with sleep disturbances is well tolerated as defined by group drop-out proportion due to issues with the mattress technology.
The study will also explore the following objectives:
Study Aim 2- To determine the efficacy of the Sound To Sleep System™ in improving parent-reported sleep quality in ASD-affected children with sleep disturbances.
Study Aim 3- To determine the tolerability of the Sound To Sleep System™ as defined by study drop-out due to any reason and caregiver ratings of ease of mattress technology use.
Study Aim 4- To determine whether use of the mattress technology improves functioning as defined by secondary outcome measures.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44104
- Cleveland Clinic Center for Autism
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ASD Diagnosis
- 2.5-12.99 Years of Age
- Sleep Difficulty as indicated by significant sleep disturbance on the Child Sleep Habits Questionnaire
- If participant is using medication or attends therapy, it must be stable four (4) weeks prior to their study participation and throughout the 5-6 week study period.
Exclusion Criteria:
- Age less than 2.5 years or more than 12.99 years
- Individuals who may have medication or therapy changes 4 weeks prior to study start date or during the study period
- An participant diagnosed with epilepsy, Fragile X, Downs Syndrome, seizure disorder, Neurofibromatosis, or Tuberous Sclerosis
- Any child with a pacemaker or other electrical device
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Mattress Technology On then Off
Intervention: Sound to Sleep System will be turned on for the first two weeks of the study allowing the participant sleeping atop the mattress to feel the vibrations synced to the audio input. Sound to sleep system will be turned on during this phase of the study. The sound to sleep system will sync an audio input with the vibrations of the mattress technology and allow the user to control the intensity of the vibration. No intervention: The mattress technology will be turned off for the second two weeks of the study. During this time, there will be no intervention. |
Sound to Sleep System is a minimal risk device that is embedded in a mattress boxspring.
The device syncs with an audio input and emits tactile vibrations in sync with the audio input.
|
EXPERIMENTAL: Mattress Technology Turned Off then On
No intervention: For the first two weeks of the study, the mattress technology will not be turned off. There will be no intervention during this time. Intervention: Sound to Sleep System will be turned on for the second two weeks of the study allowing the participant sleeping atop the mattress to feel the vibrations synced to the audio input. Sound to sleep system will be turned on during this phase of the study. The sound to sleep system will sync an audio input with the vibrations of the mattress technology and allow the user to control the intensity of the vibration. |
Sound to Sleep System is a minimal risk device that is embedded in a mattress boxspring.
The device syncs with an audio input and emits tactile vibrations in sync with the audio input.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compare Percentage of Participants Who Drop Out of Study as a Measure of Toleration of Mattress Technology
Time Frame: up to 6 weeks
|
Compare percentage of drop-out, in this cohort, due to issues with the mattress technology (e.g.
ease of use, inability to fall asleep) to a population expected drop-out rate of 30% using a one-sample proportion test.
|
up to 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Parent Reported Quality of Sleep Across Treatment Conditions
Time Frame: Average daily score, across up to 2 weeks
|
Within subjects comparison of the average daily, parent reported sleep quality across on and off conditions using a Likert-type scale of 1-7 in which 1 is "extremely poor" and 7 is "exceptional"
|
Average daily score, across up to 2 weeks
|
Total Time Asleep Recorded by Actigraphy Watch
Time Frame: Average of daily measure, across up to 2 weeks
|
Within subjects comparison of the average total sleep time (hours) in the on and off conditions as recorded by actigraphy watch
|
Average of daily measure, across up to 2 weeks
|
Total Time to Fall Asleep (Sleep Latency) Recorded by Actigraphy Watch
Time Frame: Average of daily measure, across up to 2 weeks
|
Within subjects comparison of sleep latency (minutes) recorded by actigraphy watch in the on and off conditions
|
Average of daily measure, across up to 2 weeks
|
Total Time Awake During Night Recorded by Actigraphy Watch
Time Frame: Average of daily measure, across up to 2 weeks
|
Within subjects comparison of total time awake during night (minutes) recorded by actigraphy watch in both on and off conditions
|
Average of daily measure, across up to 2 weeks
|
Percentage of Time in Bed That the Participant Spent Sleeping (Sleep Efficiency) Recorded by Actigraphy Watch.
Time Frame: Average of daily measure, across up to 2 weeks
|
Within subjects comparison of time spent sleeping (sleep efficiency as percentage) recorded by actigraphy in both the one and off conditions.
|
Average of daily measure, across up to 2 weeks
|
Caregiver-Rated Severity of Social Deficits as Measured by the Social Responsiveness Scale 2 (SRS-2)
Time Frame: Baseline, 2 weeks, 4 weeks
|
Within subjects comparison of average Social Responsiveness Scale -2 (SRS-2) T-scores in baseline, and on and off conditions. SRS-2 T-score ranges from 30-90 (M = 50, SD = 10). Higher T-scores indicate a greater extent of social communication deficits. |
Baseline, 2 weeks, 4 weeks
|
Caregiver-Rated Severity Problem Behaviors as Measured by the Aberrant Behavior Checklist (ABC)
Time Frame: Baseline, 2 weeks, 4 weeks
|
Within subjects comparison of the parent completed Aberrant Behavior Checklist (ABC) total raw score in the baseline, and on and off conditions. The ABC measures the level of challenging behavior of individuals in and across 5 subdomains (Irritability, lethargy, stereotypy, hyperactivity, inappropriate speech) using a Likert-type scale of 0-3 in which 0 is "not at all a problem" and 3 is "the problem is severe in degree". The sum raw scores of these subdomains make up the total ABC raw score (range = 0-174) in which a higher score indicates more severe challenging behaviors. |
Baseline, 2 weeks, 4 weeks
|
Caregiver-Rated Communication Problems as Measured by the CCC-2
Time Frame: Baseline, 2 weeks, 4 weeks
|
Within subjects comparison of the average Children's Communication Checklist (CCC-2) General Communication Composite standard scores across baseline, and on and off conditions. CCC-2 is a parent questionnaire that assesses children's communication skills across 10 domains using a 4-point Likert type scale (0=less than once a week/never to 3=several times a day/always). The general communication composite standard score based on age norms was used to asses overall communication competency (M=100, SD=15). Lower general communication composite scores indicate a higher likelihood of significant communication problems. |
Baseline, 2 weeks, 4 weeks
|
Caregiver-Rated Problems With Sleep Habits as Measured by the FISH
Time Frame: Baseline, 2 weeks, 4 weeks
|
Within subjects comparison of the Family Inventory of Sleep Hygiene (FISH) average total raw scores across baseline, and on and off conditions. The FISH is a parent-completed questionnaire that assesses sleep hygiene-related behaviors in children using a 5-point Likert scale (1=Never, 2=occasionally, 3=Sometimes, 4=Usually, 5=Always). Typically parents rate these behaviors with reference to the past month, but for the present study they were asked to rate for only the previous two weeks to correspond to each mattress condition. The total raw score was used to asses sleep hygiene (Range = 12-60, in which higher scores are indicative of better sleep hygiene-related behaviors). |
Baseline, 2 weeks, 4 weeks
|
Caregiver-Rated Sleep Disturbance as Measured by the Children's Sleep Habits Questionnaire (CSHQ)
Time Frame: Baseline, 2 weeks, 4 weeks
|
Within subjects comparison of the Children's Sleep Habits Questionnaire CSHQ average total raw scores across baseline and on and off conditions. The CSHQ is a parent-completed questionnaire that measures a variety of sleep-related problems using a 3-point Likert-scale (1=rarely/0 to 1 times per week, 2= sometimes/2-4 times per week, 3=usually/5-7 times per week). Ordinarily, parents rate these behaviors for the pas week but for the present study they were instructed to rate for the past two weeks to correspond to the mattress on and off conditions. The total raw scores were use to evaluate overall sleep difficulties (Range = 45-135, in which a higher score is indicative of more sleep problems). |
Baseline, 2 weeks, 4 weeks
|
Caregiver-Rated Sensory Issues Across Domains as Measured by the SSPQ
Time Frame: Baseline, 2 weeks, 4 weeks
|
Within subjects comparison of the Short Sensory Profile Questionnaire (SSPQ) average total raw scores across baseline and on and off conditions. The SSPQ is a parent-completed questionnaire that measures behaviors related to sensory processing abnormalities. Items are based on a 5-point Liker scale ranging from 1=always to 5=never. The total raw score was used to evaluate overall sensory abnormalities (Range=38-190). Lower scores indicate a higher probability of sensory processing abnormalities. |
Baseline, 2 weeks, 4 weeks
|
Caregiver-Rated of Quality of Life as Measured by the CFQL-2 Questionnaire
Time Frame: Baseline, 2 weeks, 4 weeks
|
Within subjects comparison of the Child and Family Quality of Life 2 (CFQL-2), quality of life average total raw scores across baseline and on and off conditions. The CFQL-2 is a parent questionnaire that evaluation seven different aspects of child and family quality of life (child, family, caregiver, financial, partner relationship, external support, and coping quality of life). An adapted version was used that decreased the number of total items from 32 to 26 and added an additional item to each scale to specifically evaluate changes of the past two weeks in quality of life. Items use a 5-point Likert scale ranging from (1=strongly disagree/decreased substantially to 3=neutral/same to 5=strongly agree/improved substantially). The total raw score was used to evaluate overall quality of life for child and family (Range=26-130). A lower, overall score indicates a lower quality of life for the child and their family. |
Baseline, 2 weeks, 4 weeks
|
Caregiver-Rated Measure of Challenging Behavior/Task Compliance as Measured by the Daily Sleep Diary
Time Frame: Average of daily measure, across up to 2 Weeks
|
Within subjects comparison of average challenging behavior/task compliance, measured on a scale of 1-7 in which 1 is "Extremely Difficult" and 7 is "Exceptional" in the mattress technology on and off conditions
|
Average of daily measure, across up to 2 Weeks
|
Caregiver-Rated Measure of Tolerance of Mattress Technology as Measured by the Daily Sleep Diary
Time Frame: Average of daily measure, across up to 2 Weeks
|
Comparison of average tolerance of mattress technology, measured on a scale of 1-7 in which 1 is "Extremely Poor" and 7 is "Exceptional", in the on condition compared to the median score of 4 (average toleration of mattress technology).
|
Average of daily measure, across up to 2 Weeks
|
Caregiver-Rated Measure of Tolerance of the Actigraph Watch as Measured by the Daily Sleep Diary
Time Frame: Average of daily measure, across up to 4 Weeks
|
Comparison of average tolerance of the actigraph watch, measured on a scale of 1-7 in which 1 is "Extremely Poor" and 7 is "Exceptional", across treatment conditions compared to median score of 4 (average toleration of actigraph watch).
|
Average of daily measure, across up to 4 Weeks
|
Caregiver-Rated Measure of Ease of Mattress Technology Use as Measured by the Daily Sleep Diary
Time Frame: Average of daily measure, across up to 2 Weeks
|
Comparison of ease of mattress technology use, measured on a scale of 1-7 in which 1 is "Extremely Difficult" and 7 is "Exceptionally Easy" in mattress technology on condition to median score of 4 (average ease of use of mattress technology).
|
Average of daily measure, across up to 2 Weeks
|
Caregiver-Rated Measure of Sleep Resistance as Measured by the Daily Sleep Diary
Time Frame: Average daily measure, across up to 2 Weeks
|
Within subjects comparison of average difficulty for child to go to bed, measured on a scale of 1-7 in which 1 is "Extremely Difficult" and 7 is "Exceptionally Easy", in the mattress technology on and off conditions.
|
Average daily measure, across up to 2 Weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Thomas Frazier, PhD, The Cleveland Clinic
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 14-066
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorders
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
Emory UniversityNational Institute of Mental Health (NIMH)Terminated
-
University of California, Los AngelesNational Institute of Mental Health (NIMH); Florida State University; Autism...CompletedAutism Spectrum DisordersUnited States
-
University Hospital, MontpellierCaisse Nationale de Solidarité pour l'AutonomieActive, not recruitingAutism Spectrum DisordersFrance
-
Institut National de la Santé Et de la Recherche...Completed
-
Linmarie SikichEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedAutism Spectrum DisordersUnited States
-
National Human Genome Research Institute (NHGRI)CompletedAutism Spectrum DisordersUnited States
-
University of California, San DiegoCompletedAutism Spectrum DisordersUnited States
-
Stanford UniversityNational Institute of Mental Health (NIMH)Completed
Clinical Trials on Sound to Sleep System
-
Florida International UniversityCompleted
-
Eye & ENT Hospital of Fudan UniversityUnknown
-
US Department of Veterans AffairsCompleted
-
Koko Home, Inc.Stanford UniversityRecruitingSleep Disorder | Insomnia | Sleep Initiation and Maintenance Disorders | Sleep | Sleep Disturbance | Sleep HygieneUnited States
-
Al-Quds UniversityNot yet recruitingStress | Anxiety | MRI Contrast Media Adverse Reaction
-
The Cleveland ClinicCompleted
-
CochlearAvaniaCompletedAdult Cochlear Implant RecipientsAustralia
-
University of South FloridaCompletedObesity | Insomnia | Weight Loss | Sleep Disordered Breathing | PostpartumUnited States
-
University Hospital, GenevaUnknownSleep | Intensive Care Unit Syndrome
-
Brigham and Women's HospitalThe Cleveland ClinicCompleted